Precision BioSciences Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Precision BioSciences has a total shareholder equity of $74.7M and total debt of $22.5M, which brings its debt-to-equity ratio to 30.1%. Its total assets and total liabilities are $165.8M and $91.1M respectively.

Wichtige Informationen

30.1%

Verhältnis von Schulden zu Eigenkapital

US$22.49m

Verschuldung

Zinsdeckungsgradn/a
BargeldUS$123.57m
EigenkapitalUS$74.71m
GesamtverbindlichkeitenUS$91.09m
GesamtvermögenUS$165.80m

Jüngste Berichte zur Finanzlage

Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Mar 14
Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Dec 08
Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Apr 19
Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Dec 31
Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Recent updates

Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts

It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks

Jun 23
It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks

Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Mar 14
Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Dec 08
Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Precision BioSciences appoints chief business officer from within ranks, rejigs co-founders' roles

Sep 02

Precision BioSciences: CAR T Data Updates End Of 2022 And Plenty Of Cash

Aug 16

Precision BioSciences Q2 2022 Earnings Preview

Aug 05

Precision Bio: Another CAR-T Laggard With No Solid Prospects

May 09

Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Apr 19
Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)

Mar 21
Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)

Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Dec 31
Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Precision BioSciences: Uniquely Positioned

Oct 07

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: DTIL's short term assets ($144.0M) exceed its short term liabilities ($33.0M).

Langfristige Verbindlichkeiten: DTIL's short term assets ($144.0M) exceed its long term liabilities ($58.1M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: DTIL has more cash than its total debt.

Schulden abbauen: DTIL's debt to equity ratio has increased from 0% to 30.1% over the past 5 years.

Schuldendeckung: DTIL's operating cash flow is negative, therefore debt is not well covered.

Zinsdeckung: Insufficient data to determine if DTIL's interest payments on its debt are well covered by EBIT.


Bilanz


Entdecken Sie finanziell stabile Unternehmen